CRYOPORT, INC. Debt Instrument, Face Amount
CRYOPORT, INC. (CYRX) had Debt Instrument, Face Amount of $100.00 million as of 2023-03-31, per its 10-Q filed 2023-05-04.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentFaceAmount · last filed 2023-05-04
- 2023-03-31: Debt Instrument, Face Amount $100.00M.
- 2022-12-31: Debt Instrument, Face Amount $100.00M.
- 2022-09-30: Debt Instrument, Face Amount $100.00M.
- 2022-06-30: Debt Instrument, Face Amount $100.00M.
| Period end | Debt Instrument, Face Amount |
|---|---|
| 2023-03-31 | $100.00M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $100.00M 10-K · filed 2023-02-28 |
| 2022-09-30 | $100.00M 10-Q · filed 2022-11-04 |
| 2022-06-30 | $100.00M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $100.00M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $1.00K 10-K · filed 2022-02-28 |
| 2021-09-30 | $1.00K 10-Q · filed 2021-11-04 |
| 2021-06-30 | $1.00K 10-Q · filed 2021-08-06 |
| 2021-03-31 | $1.00K 10-Q · filed 2021-05-06 |
| 2020-12-31 | $1.00K 10-K · filed 2021-03-01 |
| 2020-05-31 | $115.00M 10-Q · filed 2021-11-04 |
| 2014-12-31 | $1.79M 10-Q · filed 2015-02-05 |
| 2014-06-30 | $1.74M 10-Q · filed 2014-07-31 |
| 2014-03-31 | $1.79M 10-Q · filed 2014-11-12 |
| 2013-12-31 | $4.06M 10-Q · filed 2014-02-13 |
| 2013-09-30 | $3.91M 10-Q · filed 2013-11-18 |
| 2013-06-30 | $2.25M 10-Q · filed 2013-08-14 |
| 2013-03-31 | $1.29M 10-K · filed 2013-06-25 |
| 2012-03-31 | $334.17K 10-K · filed 2013-06-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |